MyCelx Technologies (GB:MYX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MyCelx Technologies Corporation reported its H1 2024 financial results, highlighting the sale of its Saudi Arabian operations for $3.125 million, a gross profit margin of 28.2%, and a net loss of $1.4 million. The company has seen significant operational advancements, notably in its PFAS and REGEN media technologies, securing various contracts and trials, which forecasts a promising outlook into 2025. Additionally, MyCelx successfully raised approximately $0.9 million in equity to further its trials and potentially secure more contracts in the growing PFAS remediation and EOR markets.
For further insights into GB:MYX stock, check out TipRanks’ Stock Analysis page.
